PMGC Holdings Inc. (ELAB) stock
ELABNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/3095% below fair value
$1.48−0.18 (-10.84%)
Close on Nov 17, 2026Market cap $1.32MP/E –Yield –
PMGC operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
PMGC's operating cash flow for the twelve months ending Sep 30, 2026 was -$8.98M. For fiscal 2025 it was -$5.93M.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$5.93M | – |
| FY2024 | Dec 31, 2024 | -$5.49M | – |
| FY2023 | Dec 31, 2023 | -$4.56M | – |
| FY2022 | Dec 31, 2022 | -$1.59M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$2.26M | – |
| Q2 FY2026 | Jun 30, 2026 | -$1.99M | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.98M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.75M | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.49M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.35M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.35M | – |
| Q4 FY2024 | Dec 31, 2024 | -$2.00M | – |
| Q3 FY2024 | Sep 30, 2024 | -$381.68K | – |
| Q2 FY2024 | Jun 30, 2024 | -$780.69K | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.32M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.39M | -100.2% |
| Q3 FY2023 | Sep 30, 2023 | -$514.40K | – |
| Q2 FY2023 | Jun 30, 2023 | -$768.76K | – |
| Q1 FY2023 | Mar 31, 2023 | -$885.51K | – |
| Q4 FY2022 | Dec 31, 2022 | $1.08B | – |
See a number that looks wrong?